Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mohamed Ali, Mohamed Raslan, Michał Ciebiera, Kornelia Zaręba & Ayman Al-Hendy. (2022) Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids. Expert Opinion on Drug Safety 21:4, pages 477-486.
Read now
Read now
Mohamed Ali, Hsin-Yuan Chen, Yi-Fen Chiang, Osama A Badary, Shih-Min Hsia & Ayman Al-Hendy. (2022) An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Opinion on Pharmacotherapy 23:4, pages 421-429.
Read now
Read now
Articles from other publishers (10)
Mohamed Ali, Michał Ciebiera, Marta Wlodarczyk, Samar Alkhrait, Elise Maajid, Qiwei Yang, Shih-Min Hsia & Ayman Al-Hendy. (2023) Current and Emerging Treatment Options for Uterine Fibroids. Drugs.
Crossref
Crossref
Shikha Singh, Praveen Kumar, Kavita, Saurabh Singh Rathore, Yashasvi Singh & Neha Garg. (2023) Contemporary approaches in the management of uterine leiomyomas. European Journal of Obstetrics & Gynecology and Reproductive Biology 287, pages 195-210.
Crossref
Crossref
Becky MacGregor, Malcolm G. Munro & Mary Ann Lumsden. (2023) Therapeutic options for the management of abnormal uterine bleeding. International Journal of Gynecology & Obstetrics 162:S2, pages 43-57.
Crossref
Crossref
Samuele Ciceri, Diego Colombo, Enrico M. A. Fassi, Patrizia Ferraboschi, Giovanni Grazioso, Paride Grisenti, Marco Iannone, Carlo Castellano & Fiorella Meneghetti. (2023) Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study. Molecules 28:9, pages 3861.
Crossref
Crossref
Mohamed Ali, David Stone, Archana Laknaur, Qiwei Yang & Ayman Al-Hendy. (2023) EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate. F&S Science.
Crossref
Crossref
Narvella Sefah, Sithembinkosi Ndebele, Lillian Prince, Elizabeth Korasare, Michael Agbleke, Annabella Nkansah, Humphrey Thompson, Ayman Al-Hendy & Andrews Akwasi Agbleke. (2023) Uterine fibroids — Causes, impact, treatment, and lens to the African perspective. Frontiers in Pharmacology 13.
Crossref
Crossref
Nicholas Leyland, Mathew Leonardi, Ally Murji, Sukhbir S. Singh, Ayman Al-Hendy & Linda Bradley. (2022) A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids. Reproductive Sciences 29:4, pages 1188-1196.
Crossref
Crossref
Mei-Jie Yang, Ren-Qiang Yu, Jin-Yun Chen & Zhi-Biao Wang. (2021) Comparison of Dose and Effectiveness of a Single-Session Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids With Different Sizes. Frontiers in Oncology 11.
Crossref
Crossref
Qiong Wang, Er-Min Gu, Chaojie Chen, Ren-ai Xu & Shunbin Luo. (2021) Analytical methodology and pharmacokinetic study of elagolix in plasma of rats using a newly developed UPLC-MS/MS assay. Arabian Journal of Chemistry 14:7, pages 103235.
Crossref
Crossref
Mei-Jie Yang, Ren-Qiang Yu, Wen-zhi Chen, Jin-Yun Chen & Zhi-Biao Wang. (2021) A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids. Frontiers in Surgery 8.
Crossref
Crossref